My Lords, I am grateful for the opportunity to update the House on the UK’s international response to Covid-19—the biggest threat that we have faced in decades. A global pandemic needs a global response, and the international community must work together to tackle this virus so that we can all be safe from future waves of infection.
The UK has a proud history of leading international efforts to tackle global problems. Despite the challenges we are facing at home, we are determined to fulfil our role in the international response. The UK has been playing, and will continue to play, a leading role in galvanising the most effective co-ordinated international action through our international strategy, leadership and partners. We are tackling this crisis using the full range of development, diplomatic, national security, prosperity and influencing tools to address the direct and wide-ranging secondary impacts.
We are funding global research into therapeutics, diagnostics and a vaccine, recognising the urgent need to equitably distribute a treatment once it becomes available. We are protecting the poorest and most vulnerable people and working to ensure that no one is left behind. We are supporting British nationals across the world and getting people home when we can; and, of course, we are looking to the future and investing in a clean and resilient global recovery.
Our UK aid support has reinforced our international leadership. The Prime Minister, Foreign Secretary, Chancellor, and Health and DfID Secretaries of State have all been actively engaging in dialogue with world leaders and other international groups—and our engagement is making a difference. We are playing a key role in the multilateral response to Covid-19. We have encouraged the G7 and G20 to act, and have called on international organisations to co-ordinate and increase support for vulnerable countries and to deliver the appropriate international financial and health system assistance.
Working with our G20 partners, we have ensured that critical supply chains remain open for food and medicines, and we have driven agreement on the finance ministers’ action plan for the immediate response and a clean and resilient recovery.
We are investing in vaccines and global health. The UK is proud to have world-class scientific and medical research facilities. British scientists have driven major breakthroughs throughout the history of global health, in epidemiology, immunology and vaccinations. Continuing this tradition, the Government’s Vaccine Taskforce has just provided an additional £84 million of new funding for Covid-19 vaccine manufacturing at Oxford University and Imperial College, bringing the total government investment for these institutions to over £130 million.
The Oxford team is also working in partnership with the great British company AstraZeneca to ensure that any successful vaccine could be rapidly produced to meet global demand. The agreement will deliver 100 million doses in total, ensuring that in addition to supporting our own people we are able to make vaccines available to developing countries at the lowest possible cost. British researchers who built diagnostic kits for Ebola are also working on new rapid diagnostics for Covid-19.